SCHEMBL7980228

SCHEMBL7980228

Clc1cc(Cl)c(Nc2nc3ccccc3n3cncc23)c(Cl)c1

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7982128 0.90 LCK (1.00) LCK
SCHEMBL7979997 0.86 LCK (0.73) LCK
SCHEMBL7982170 0.85 LCK (0.79) LCK
SCHEMBL7979903 0.85 LCK (0.70) LCK
SCHEMBL7987291 0.84 LCK (1.00) LCK
SCHEMBL7983700 0.83 LCK (0.84) LCK
SCHEMBL7983172 0.82 LCK (0.71) LCK
SCHEMBL7979866 0.82 LCK (1.00) LCK
SCHEMBL7981428 0.82 LCK (0.80) LCK
SCHEMBL7969709 0.81 LCK (1.00) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed